MAPKAPK2, a potential dynamic network biomarker of α-synuclein prior to its aggregation in PD patients
Abstract One of the important pathological features of Parkinson’s disease (PD) is the pathological aggregation of α-synuclein (α-Syn) in the substantia nigra. Preventing the aggregation of α-Syn has become a potential strategy for treating PD. However, the molecular mechanism of α-Syn aggregation i...
Main Authors: | Zhenggang Zhong, Jiabao Li, Jiayuan Zhong, Yilin Huang, Jiaqi Hu, Piao Zhang, Baowen Zhang, Yabin Jin, Wei Luo, Rui Liu, Yuhu Zhang, Fei Ling |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-03-01
|
Series: | npj Parkinson's Disease |
Online Access: | https://doi.org/10.1038/s41531-023-00479-z |
Similar Items
-
Inhibition of α-Synuclein Aggregation by the Interaction Between Protein Disulfide Isomerase and α-Synuclein
by: PEI Yun-shan1,2, ZHANG Cai1,2, LIU Xiao-li1, CHENG Kai1, ZHANG Ze-ting,1, LI Cong-gang1
Published: (2022-12-01) -
Monitoring α-synuclein aggregation
by: Juan Estaun-Panzano, et al.
Published: (2023-01-01) -
The stress-responsive kinases MAPKAPK2/MAPKAPK3 activate starvation-induced autophagy through Beclin 1 phosphorylation
by: Yongjie Wei, et al.
Published: (2015-02-01) -
Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
by: Tingting Du, et al.
Published: (2021-03-01) -
Inducing α-synuclein compaction: a new strategy for inhibiting α-synuclein aggregation?
by: Francisca Pinheiro, et al.
Published: (2019-01-01)